Enhanced proatherogenic responses in macrophages and vascular smooth muscle cells derived from diabetic db/db mice

Shu Iian Li, Marpadga A. Reddy, Qiangjun Cai, Li Meng, Hang Yuan, Linda Lanting, Rama Natarajan

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Diabetes is associated with enhanced inflammatory responses and cardiovascular complications such as atherosclerosis. However, it is unclear whether similar responses are present in cells derived from experimental animal models of diabetes. We examined our hypothesis that macrophages and short-term cultured vascular smooth muscle cells (VSMCs) derived from obese, insulin-resistant, and diabetic db/db mice would exhibit increased proatherogenic responses relative to those from control db/+ mice. We observed that macrophages from db/db mice exhibit significantly increased expression of key inflammatory cytokines and chemokines as well as arachidonic acid-metabolizing enzymes cyclooxygenase-2 and 12/15-lipoxygenase that generate inflammatory lipids. Furthermore, VSMCs derived from db/db mice also showed similar enhanced expression of inflammatory genes. Expression of inflammatory genes was also significantly increased in aortas derived from db/db mice. Both macrophages and VSMCs from db/db mice demonstrated significantly increased oxidant stress, activation of key signaling kinases, and transcription factors cAMP response element-binding protein and nuclear factor-{kappa}B, involved in the regulation of atherogenic and inflammatory genes. Interestingly, VSMCs from db/db mice displayed enhanced migration as well as adhesion to WEHI mouse monocytes relative to db/+. Thus, the diabetic milieu and a potential hyperglycemic memory can induce aberrant behavior of vascular cells. These new results demonstrate that monocyte/macrophages and VSMCs derived from db/db mice display a "preactivated" and proinflammatory phenotype associated with the pathogenesis of diabetic vascular dysfunction and atherosclerosis.

Original languageEnglish (US)
Pages (from-to)2611-2619
Number of pages9
JournalDiabetes
Volume55
Issue number9
DOIs
StatePublished - Sep 2006
Externally publishedYes

Fingerprint

Vascular Smooth Muscle
Smooth Muscle Myocytes
Macrophages
Blood Vessels
Monocytes
Atherosclerosis
Gene Expression
Cyclic AMP Response Element-Binding Protein
NF-kappa B
Cyclooxygenase 2
Chemokines
Arachidonic Acid
Oxidants
Aorta
Transcription Factors
Phosphotransferases
Animal Models
Insulin
Cytokines
Phenotype

Keywords

  • AGE, advanced glycation end product
  • COX-2, cyclooxygenase-2
  • CREB, cAMP response element-binding protein
  • DME, Dulbecco's modified Eagle's
  • ELISA, enzyme-linked immunosorbent assay
  • ERK, extracellular signal-regulated kinase
  • IFN, interferon

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Enhanced proatherogenic responses in macrophages and vascular smooth muscle cells derived from diabetic db/db mice. / Li, Shu Iian; Reddy, Marpadga A.; Cai, Qiangjun; Meng, Li; Yuan, Hang; Lanting, Linda; Natarajan, Rama.

In: Diabetes, Vol. 55, No. 9, 09.2006, p. 2611-2619.

Research output: Contribution to journalArticle

Li, Shu Iian ; Reddy, Marpadga A. ; Cai, Qiangjun ; Meng, Li ; Yuan, Hang ; Lanting, Linda ; Natarajan, Rama. / Enhanced proatherogenic responses in macrophages and vascular smooth muscle cells derived from diabetic db/db mice. In: Diabetes. 2006 ; Vol. 55, No. 9. pp. 2611-2619.
@article{4ed21eebfd0a47679be86387006abbbd,
title = "Enhanced proatherogenic responses in macrophages and vascular smooth muscle cells derived from diabetic db/db mice",
abstract = "Diabetes is associated with enhanced inflammatory responses and cardiovascular complications such as atherosclerosis. However, it is unclear whether similar responses are present in cells derived from experimental animal models of diabetes. We examined our hypothesis that macrophages and short-term cultured vascular smooth muscle cells (VSMCs) derived from obese, insulin-resistant, and diabetic db/db mice would exhibit increased proatherogenic responses relative to those from control db/+ mice. We observed that macrophages from db/db mice exhibit significantly increased expression of key inflammatory cytokines and chemokines as well as arachidonic acid-metabolizing enzymes cyclooxygenase-2 and 12/15-lipoxygenase that generate inflammatory lipids. Furthermore, VSMCs derived from db/db mice also showed similar enhanced expression of inflammatory genes. Expression of inflammatory genes was also significantly increased in aortas derived from db/db mice. Both macrophages and VSMCs from db/db mice demonstrated significantly increased oxidant stress, activation of key signaling kinases, and transcription factors cAMP response element-binding protein and nuclear factor-{kappa}B, involved in the regulation of atherogenic and inflammatory genes. Interestingly, VSMCs from db/db mice displayed enhanced migration as well as adhesion to WEHI mouse monocytes relative to db/+. Thus, the diabetic milieu and a potential hyperglycemic memory can induce aberrant behavior of vascular cells. These new results demonstrate that monocyte/macrophages and VSMCs derived from db/db mice display a {"}preactivated{"} and proinflammatory phenotype associated with the pathogenesis of diabetic vascular dysfunction and atherosclerosis.",
keywords = "AGE, advanced glycation end product, COX-2, cyclooxygenase-2, CREB, cAMP response element-binding protein, DME, Dulbecco's modified Eagle's, ELISA, enzyme-linked immunosorbent assay, ERK, extracellular signal-regulated kinase, IFN, interferon",
author = "Li, {Shu Iian} and Reddy, {Marpadga A.} and Qiangjun Cai and Li Meng and Hang Yuan and Linda Lanting and Rama Natarajan",
year = "2006",
month = "9",
doi = "10.2337/db06-0164",
language = "English (US)",
volume = "55",
pages = "2611--2619",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "9",

}

TY - JOUR

T1 - Enhanced proatherogenic responses in macrophages and vascular smooth muscle cells derived from diabetic db/db mice

AU - Li, Shu Iian

AU - Reddy, Marpadga A.

AU - Cai, Qiangjun

AU - Meng, Li

AU - Yuan, Hang

AU - Lanting, Linda

AU - Natarajan, Rama

PY - 2006/9

Y1 - 2006/9

N2 - Diabetes is associated with enhanced inflammatory responses and cardiovascular complications such as atherosclerosis. However, it is unclear whether similar responses are present in cells derived from experimental animal models of diabetes. We examined our hypothesis that macrophages and short-term cultured vascular smooth muscle cells (VSMCs) derived from obese, insulin-resistant, and diabetic db/db mice would exhibit increased proatherogenic responses relative to those from control db/+ mice. We observed that macrophages from db/db mice exhibit significantly increased expression of key inflammatory cytokines and chemokines as well as arachidonic acid-metabolizing enzymes cyclooxygenase-2 and 12/15-lipoxygenase that generate inflammatory lipids. Furthermore, VSMCs derived from db/db mice also showed similar enhanced expression of inflammatory genes. Expression of inflammatory genes was also significantly increased in aortas derived from db/db mice. Both macrophages and VSMCs from db/db mice demonstrated significantly increased oxidant stress, activation of key signaling kinases, and transcription factors cAMP response element-binding protein and nuclear factor-{kappa}B, involved in the regulation of atherogenic and inflammatory genes. Interestingly, VSMCs from db/db mice displayed enhanced migration as well as adhesion to WEHI mouse monocytes relative to db/+. Thus, the diabetic milieu and a potential hyperglycemic memory can induce aberrant behavior of vascular cells. These new results demonstrate that monocyte/macrophages and VSMCs derived from db/db mice display a "preactivated" and proinflammatory phenotype associated with the pathogenesis of diabetic vascular dysfunction and atherosclerosis.

AB - Diabetes is associated with enhanced inflammatory responses and cardiovascular complications such as atherosclerosis. However, it is unclear whether similar responses are present in cells derived from experimental animal models of diabetes. We examined our hypothesis that macrophages and short-term cultured vascular smooth muscle cells (VSMCs) derived from obese, insulin-resistant, and diabetic db/db mice would exhibit increased proatherogenic responses relative to those from control db/+ mice. We observed that macrophages from db/db mice exhibit significantly increased expression of key inflammatory cytokines and chemokines as well as arachidonic acid-metabolizing enzymes cyclooxygenase-2 and 12/15-lipoxygenase that generate inflammatory lipids. Furthermore, VSMCs derived from db/db mice also showed similar enhanced expression of inflammatory genes. Expression of inflammatory genes was also significantly increased in aortas derived from db/db mice. Both macrophages and VSMCs from db/db mice demonstrated significantly increased oxidant stress, activation of key signaling kinases, and transcription factors cAMP response element-binding protein and nuclear factor-{kappa}B, involved in the regulation of atherogenic and inflammatory genes. Interestingly, VSMCs from db/db mice displayed enhanced migration as well as adhesion to WEHI mouse monocytes relative to db/+. Thus, the diabetic milieu and a potential hyperglycemic memory can induce aberrant behavior of vascular cells. These new results demonstrate that monocyte/macrophages and VSMCs derived from db/db mice display a "preactivated" and proinflammatory phenotype associated with the pathogenesis of diabetic vascular dysfunction and atherosclerosis.

KW - AGE, advanced glycation end product

KW - COX-2, cyclooxygenase-2

KW - CREB, cAMP response element-binding protein

KW - DME, Dulbecco's modified Eagle's

KW - ELISA, enzyme-linked immunosorbent assay

KW - ERK, extracellular signal-regulated kinase

KW - IFN, interferon

UR - http://www.scopus.com/inward/record.url?scp=33750589423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750589423&partnerID=8YFLogxK

U2 - 10.2337/db06-0164

DO - 10.2337/db06-0164

M3 - Article

VL - 55

SP - 2611

EP - 2619

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 9

ER -